Study of Canakinumab in Patients With Myelofibrosis

Clinical trial NCT05467800 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05467800
Sponsor: John Mascarenhas
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-essential Thrombocythemia Myelofibrosis ET-MF Post-polycythemia Vera Related Myelofibrosis PV-MF

Start date: 2022-08-02
Primary completion: 2026-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.